JAKi trial summary for index.png

Bench-to-bedside: JAK Inhibitor plus Anti-PD1 for NSCLC

 

Pre-Clinical Studies in Mice Informed Clinical Trial Design

UNDER CONSTRUCTION

For now, take a look at this Tweetorial

https://x.com/andyjminn/status/1804695892022214998